Rheumatoid arthritis is a long-term disease that causes inflammation of the joints and tissues.
“Recent studies have suggested immunomodulatory and anti-inflammatory effects of cannabinoid receptor 2 (CB2R) activation”, states the study’s abstract.
Despite these recent studies, researchers say that the connection between these cannabinoid receptors and rheumatoid arthritis has been much less observed, leading them to conduct this study.
According to their researchers, data suggests that “CB2R may be a potential therapeutic target of RA [rheumatoid arthritis].”
The study will appear in this month’s issue of the Oxford journal Rheumatology. and was conducted by researchers at Changhai Hospital, the Second Military Medical University and Shanghai Guanghua Hospital, all in China.